SARA PEASE: Open Payments
NPI 1972792059 · EAST LIVERPOOL, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 11 payments from 7 companies in 2025. Trend: 2023 $233 · 2024 $336 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $71 |
| REVANCE THERAPEUTICS, INC. | 1 | $58 |
| Alkermes, Inc. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Gilead Sciences, Inc. | 1 | $21 |
| Braeburn Inc. | 1 | $16 |
Products named: DAXXIFY, SKYRIZI, REXULTI, Auvelity, VIVITROL, ARISTADA, BRIXADI, MAVYRET.
Industry payments across OH — which companies pay providers there.
